TAG:
dna analysis
February 29, 2016 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume XXIII No. 3 – February 29, 2016 Issue
Sandy, Utah-based Sure Genomics is the latest genetic testing company to get a letter from the Food and Drug Administration asking why the company is marketing its SureDNA genetic testing kit to consumers without first obtaining clearance from the federal agency. Th…
Pathology Labs Want Method To Correct Specimen ID Errors
By Joseph Burns | From the Volume XX No. 1 – January 22, 2013 Issue
CEO SUMMARY: When pathology labs discover instances of a misidentified or contaminated tissue specimen, there is a new service that allows them to retrospectively use DNA to properly match that specimen to the correct patient. In part two of our series, we look at how some pathology labs …
New Business Helps Reduce Pathology Specimen ID Errors
By Joseph Burns | From the Volume XIX No. 17 – December 10, 2012 Issue
CEO SUMMARY: Prevention of diagnostic testing errors is getting more attention by both physicians and pathology labs because patients are less tolerant of potentially life-changing errors. Strand Diagnostics’ Know Error system is designed to reduce or eliminate errors involving tissue s…
Roche Offers $5.7 Billion To Acquire Illumina Inc.
By Joseph Burns | From the Volume XIX No. 2 – January 30, 2012 Issue
CEO SUMMARY: Once again, Roche is hunting for gene sequencing and gene analysis technology that can support its goal of being a world leader in gene-based therapeutics and clinical lab testing that utilizes gene tests and molecular diagnostics. Last week, Roche launched a hostile stock te…
December 19, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 17 – December 19, 2011 Issue
Expanded genetic testing for cancer patients in the United Kingdom is one goal of a new effort by the Stratified Medicine Programme at Cancer Research UK. Officials want to ensure that the right genetic tests are available to support use of new therapeutic drugs for …
French Company Buys Pittsburgh-Based RedPath
By Robert Michel | From the Volume XVII No. 7 – May 10, 2010 Issue
CEO SUMMARY: Here’s a deal that is all about proprietary molecular assays and access to new markets. With its purchase of RedPath Integrated Pathology, ExonHit Therapeutics, S.A., of Paris, France, gains a CLIA laboratory and access to the U.S. market, even as the new owner ope…
“December 1, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 16 – December 1, 2003 Issue
Lab-Interlink Inc. of Omaha, Nebraska is heading to bankruptcy court. On November 24, the day before Thanksgiving, the company laid off 50 employees. Rodney Markin, M.D., Ph.D., Company founder and Chairman stated that an expected $1 million payment by a prospective buyer had not mat…
LabCorp to Help Collect Family DNA Specimens
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: DNA testing will be a primary tool in identifying victims of this major disaster. Officials in New York City are formulating a plan whereby private labs will do DNA testing in conjunction with New York State Police laboratories. Laboratory Corporation of America has been desi…
How Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized